Search Results - "Urano, Yasuharu"

  • Showing 1 - 7 results of 7
Refine Results
  1. 1

    Discovery of novel forkhead box O1 inhibitors for treating type 2 diabetes: improvement of fasting glycemia in diabetic db/db mice by Nagashima, Takeyuki, Shigematsu, Nobuharu, Maruki, Riyo, Urano, Yasuharu, Tanaka, Hirotsugu, Shimaya, Akiyoshi, Shimokawa, Teruhiko, Shibasaki, Masayuki

    Published in Molecular pharmacology (01-11-2010)
    “…Excessive hepatic glucose production through the gluconeogenesis pathway is partially responsible for the elevated glucose levels observed in patients with…”
    Get more information
    Journal Article
  2. 2
  3. 3

    Effects of the novel Foxo1 inhibitor AS1708727 on plasma glucose and triglyceride levels in diabetic db/db mice by Tanaka, Hirotsugu, Nagashima, Takeyuki, Shimaya, Akiyoshi, Urano, Yasuharu, Shimokawa, Teruhiko, Shibasaki, Masayuki

    Published in European journal of pharmacology (25-10-2010)
    “…Recent evidence suggests that the forkhead transcription factor Foxo1 plays an important role in the regulation of glucose and triglyceride metabolism at the…”
    Get full text
    Journal Article
  4. 4
  5. 5

    Prevention of renal interstitial fibrosis via histone deacetylase inhibition in rats with unilateral ureteral obstruction by Kinugasa, Fumitaka, Noto, Takahisa, Matsuoka, Hideaki, Urano, Yasuharu, Sudo, Yuji, Takakura, Shoji, Mutoh, Seitaro

    Published in Transplant immunology (01-05-2010)
    “…Abstract Acute rejection following renal transplantation has become manageable with the introduction of calcineurin inhibitors, FK506 and cyclosporine A…”
    Get full text
    Journal Article
  6. 6
  7. 7

    FR226807: a potent and selective phosphodiesterase type 5 inhibitor by Hosogai, Naomi, Hamada, Kaori, Tomita, Masayuki, Nagashima, Akira, Takahashi, Tokiko, Sekizawa, Toshihiro, Mizutani, Tsuyoshi, Urano, Yasuharu, Kuroda, Akio, Sawada, Kozo, Ozaki, Tohru, Seki, Jiro, Goto, Toshio

    Published in European journal of pharmacology (05-10-2001)
    “…We describe the pharmacological characteristics of a novel phosphodiesterase type 5 inhibitor FR226807, N-(3,4-dimethoxybenzyl)-2-{[(1…”
    Get full text
    Journal Article